sanofi42m
Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease
Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the ...
sanofi56m
Press Release: Availability of the Q4 2024 Aide-mémoire
Sanofi announced today that its Q4 2024 Aide-mémoire is available on the "Investors" page of the company's website: ...